HI
APGN

Harbour Investments’s Apexigen, Inc. Common Stock APGN Stock Holding History

Harbour Investments’s Portfolio APGN Stock Details APGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$37K Sell
3,717
-1,017
-21% -$10.1K ﹤0.01% 1401
2021
Q3 		$47K Sell
4,734
-11,161
-70% -$110K ﹤0.01% 1812
2021
Q2 		$158K Sell
15,895
-587
-4% -$5.82K 0.01% 1160
2021
Q1 		$162K Buy
+16,482
New +$165K 0.01% 1071

Other funds holding APGN

PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
KC
Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return
KIM
Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return
FTCM
Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return
BCM
Basso Capital Management Stamford, Connecticut $163M AUM 21.95% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return

Harbour Investments's APGN Position: Q4 2021 in Review

Harbour Investments reduced its Apexigen, Inc. Common Stock (APGN) stake by 21% in Q4 2021, selling an estimated $10.1K and leaving 3,717 shares worth $37K. The position accounts for ﹤0.01% of the portfolio, ranked #1401.

Harbour Investments first reported a position in APGN in Q1 2021 and has held it in 4 quarters since. The position peaked at $162K in Q1 2021. 38 funds tracked by Wall St. Rank hold APGN as of Q4 2021.

  • Harbour Investments held 3,717 shares of Apexigen, Inc. Common Stock worth $37K as of Q4 2021.
  • Harbour Investments sold 1,017 Apexigen, Inc. Common Stock shares in Q4 2021, an estimated $10.1K.
  • Apexigen, Inc. Common Stock made up ﹤0.01% of Harbour Investments's portfolio in Q4 2021, its #1401 holding.
  • Harbour Investments first reported a position in Apexigen, Inc. Common Stock in Q1 2021 and has held it in 4 quarters since.
  • Harbour Investments's Apexigen, Inc. Common Stock position peaked at $162K in Q1 2021.
  • 38 funds tracked by Wall St. Rank held Apexigen, Inc. Common Stock as of Q4 2021.

Based on Harbour Investments's 13F filing for Q4 2021, filed 16 Feb 2022.